Lymphoma, Non-Hodgkin's, Adult

Oncology
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Salarius Pharmaceuticals
1 program
1
SP-3164Phase 11 trial
Active Trials
NCT05979857Not Yet Recruiting72Est. Aug 2027

Trial Timeline

Clinical trial activity over time

2024
2025
2026
2027
Salarius PharmaceuticalsSP-3164

Clinical Trials (1)

Total enrollment: 72 patients across 1 trials

Study of SP-3164 in Relapsed or Refractory Non-Hodgkin's Lymphoma

Start: Mar 2024Est. completion: Aug 202772 patients
Phase 1Not Yet Recruiting

Related Jobs in Oncology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space